News about Regulation

MEDITECH STACKATHON 2024 Launched to Propel India's MedTech Sector Towards Innovation

Dr. Chawla emphasized the immense potential of India's MedTech industry, projecting a growth rate of 28 percent annually, with estimates indicating a market size of USD 50 billion by 2030.

Regulation | 08/05/2024 | By Abha |  671

Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards

The revised scheme, a significant step in the government's efforts, follows a comprehensive review by the Scheme Steering Committee.

Regulation | 12/03/2024 | By Abha |  530

Prime Minister Sets Foundation for Revolutionary Healthcare Project in Nandurbar, Being Executed by Jakson Group

With an investment of more than Rs 600 Crores, the project includes the construction of the medical college, hospital, and related buildings, dedicated to enhancing healthcare services for tribal communities and the wider population of Nandurbar and is expected to be completed by February 2026.

Regulation | 27/02/2024 | By Manvi |  681

Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis

The campaign, covering 92 districts across 11 states, will span the next two weeks.

Regulation | 10/02/2024 | By Manvi |  553

India's Ministry of Health Revises Pharmaceutical Manufacturing Rules

The move is seen as a step towards aligning with international quality standards and ensuring the production of safe and high-quality drugs.

Regulation | 08/01/2024 | By Manvi |  699

Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector

Union Cabinet has already approved the National Policy on Research and Development and Innovation in the Pharma-Med Tech Sector in India.

Regulation | 30/08/2023 | By Manvi |  767

USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma

The Company is committed to address the observations and will submit its response to USFDA within the stipulated time.

Regulation | 28/08/2023 | By Manvi |  512

Gland Pharma Receives EIR From USFDA For Dundigal Facility

Gland Pharma shares gained nearly 3 percent in trade after receiving EIR.

Regulation | 25/08/2023 | By Manvi |  582

Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility

The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.

Regulation | 25/08/2023 | By Manvi |  932

Glenmark Pharma settles drug pricing case with US Department of Justice

Glenmark Pharma settles drug pricing case with US Department of Justice

Regulation | 24/08/2023 | By Sudeep Soparkar |  502